Evolving Diagnostic and Management Advances in Coronary Heart Disease

Ribeiro, Matheus de Oliveira Laterza; Correia, Vinícius Machado; Oliveira, Lucas Lentini Herling de; Soares, Paulo Rogério; Scudeler, Thiago Luis

doi:10.3390/life13040951

Cited by 6 publications

(4 citation statements)

References 211 publications

(242 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diagnosis of CHD was established based on coronary angiography or other imaging tests indicating coronary artery stenosis or obstruction exceeding 50% [ 20 ]. Pre-existing CHD was defined as a reported patient history of CHD upon admission.…”

Section: Methodsmentioning

confidence: 99%

Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

Wang,

Zhu,

Zhang

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients with pre-existing CHD remains uncertain primarily due to the limited number of patients in existing studies. This study aimed to investigate the impacts of pre-existing CHD on the prognosis of COVID-19 patients. Five electronic databases were searched for eligible studies. This article focused on cohort and case-control studies involving the prognosis of COVID-19 patients with pre-existing CHD. The meta-analysis was performed using a random effects model. The odds ratios (ORs) and 95% confidence intervals (CIs) were used as valid indicators. The study was registered in PROSPERO with the identifier: CRD42022352853. A total of 81 studies, involving 157,439 COVID-19 patients, were included. The results showed that COVID-19 patients with pre-existing CHD exhibited an elevated risk of mortality (OR = 2.45; 95%CI: [2.04, 2.94], P < 0.001), severe/critical COVID-19 (OR = 2.57; 95%CI: [1.98, 3.33], P < 0.001), Intensive Care Unit or Coronary Care Unit (ICU/CCU) admission: (OR = 2.75, 95%CI: [1.61, 4.72], P = 0.002), and reduced odds of discharge/recovery (OR = 0.43, 95%CI: [0.28, 0.66], P < 0.001) compared to COVID-19 patients without pre-existing CHD. Subgroup analyses indicated that the prognosis of COVID-19 patients with pre-existing CHD was influenced by publication year, follow-up duration, gender, and hypertension. In conclusion, pre-existing CHD significantly increases the risk of poor prognosis in patients with COVID-19, particularly in those male or hypertensive patients.

show abstract

Section: Methodsmentioning

confidence: 99%

Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

Wang,

Zhu,

Zhang

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…There have been several advances in cardiovascular imaging, such as 3D echocardiography, cardiac MRI, and PET imaging, which can provide detailed information on the structure and function of the heart and blood vessels [18]. These imaging techniques can detect early signs of CVDs and provide more accurate diagnoses.…”

Section: Cardiovascular Imagingmentioning

confidence: 99%

Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention

Addissouky,

El Tantawy El Sayed,

Ali

et al. 2024

J Clin Cardiol

View full text Add to dashboard Cite

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Effective prevention and management strategies are essential to reduce the burden of CVDs. This review summarizes recent advances in the prevention and management of CVDs. In terms of prevention, lifestyle modifications, such as diet, exercise, and smoking cessation, remain important strategies. Pharmacological interventions, including statins, antiplatelet agents, and antihypertensive medications, have also shown benefits. Innovative approaches, such as genetic testing and risk stratification, targeted prevention strategies, and the use of mobile health technology, are being explored. In terms of management, acute management strategies, such as reperfusion therapy for myocardial infarction, acute heart failure management, and stroke management, have improved outcomes. Chronic management strategies, including medical therapy for heart failure, arrhythmia management, and device therapy for heart failure, have also shown benefits. Innovative approaches, such as precision medicine and personalized treatment, the use of artificial intelligence in diagnosis and treatment, and advances in traditional Chinese and regenerative medicine, are being investigated. While recent advances in the prevention and management of CVDs are promising, challenges remain in implementing these strategies, including cost-effectiveness, access to care, and resistance to change in clinical practice. Continued research and innovation are essential to reduce the burden of CVDs and improve patient outcomes.

show abstract

“…Non-invasive imaging methods have considerably advanced the medical diagnosis of coronary artery conditions and have enabled the exact visualisation of the coronary composition and myocardial features [ 5 ]. Specifically, coronary computed tomography angiography (CCTA) has become an effective device for the non-invasive examination of coronary arteries because it provides high-resolution photos and enables the precise discovery of coronary constriction and plaque.…”

Section: Reviewmentioning

confidence: 99%

Updates in the Management of Coronary Artery Disease: A Review Article

Bansal,

Hiwale

2023

Cureus

View full text Add to dashboard Cite

Coronary artery disease (CAD) remains a significant health challenge, imposing substantial burdens on individuals and healthcare systems worldwide. CAD's impact stems from artery narrowing and blockage, leading to severe complications like heart attacks and heart failure. Collaborative efforts by researchers, professionals, and governments have fostered advancements in comprehending and managing this cardiovascular ailment. Evolving CAD management embraces modern diagnostics, cutting-edge pharmaceuticals, invasive procedures, lifestyle modifications, and cardiac rehabilitation. This comprehensive approach aims to amplify outcomes and elevate the quality of life for CAD-affected individuals. This review delves into innovative treatments, pivotal breakthroughs, and recent trends in clinical practices that collectively shape CAD management. The exploration encompasses novel diagnostic technologies enabling early detection and risk assessment. Moreover, it investigates recent breakthroughs in medications that profoundly impact platelet disorders, lipid reduction, and angina. Precision medicine's role in tailoring treatment strategies based on patient characteristics is thoroughly examined. Advances in invasive procedures, like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), have revolutionised coronary revascularisation, substantially improved long-term outcomes, and reduced restenosis rates. The increasing significance of lifestyle changes and cardiac rehabilitation in CAD management, augmenting treatment options and patient recovery, are meticulously scrutinized. While these strides are pivotal, research continues to chart new paths in CAD management, from innovative drugs to collaborative multidisciplinary care models. Staying attuned to the latest advancements and embracing a patient-centric approach can collectively reduce CAD's impact and facilitate the lives of those grappling with this chronic cardiovascular disorder.

show abstract

Evolving Diagnostic and Management Advances in Coronary Heart Disease

Cited by 6 publications

References 211 publications

Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention

Updates in the Management of Coronary Artery Disease: A Review Article

Contact Info

Product

Resources

About